Women with low-grade serous ovarian cancer are needed for a study to evaluate an investigational drug alone or in combination with a 2nd investigational drug.

The University of Virginia Cancer Center is conducting a clinical research study for women who are adults ages 18 and over, and have low-grade serous ovarian cancer. The purpose of this study to evaluate an investigational drug (VS-6766) alone or in combination with another investigational drug (defactinib) in participants with ovarian cancer. The effects of the investigational drugs alone or in combination will be evaluated for this study.

Participation includes taking the study drug(s) orally for as long as the study treatment is still helping your disease, with a longer term follow-up via a clinic visit or a phone call to keep track of how you’re doing. Study specific test will be provided at no cost to you.

Additional information can be found here: https://www.clinicaltrials.gov/ct2/show/NCT04625270